GGrantIndex
← Leaderboards

Jayanta Chaudhuri

Sloan-Kettering Inst Can Research

$12,246,137
Attributed
$12,246,137
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,246,137 · 4

By mechanism

R01$11,169,388 · 2
U54$545,749 · 1
R56$531,000 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “B-Lymphocytes

Research focus

B-LymphocytesCellsImmune ResponseDna Double Strand BreakImmunologic Deficiency SyndromesGenerationsLesionActivation-Induced Cytidine DeaminaseImmunoglobulin Switch RecombinationMature B-LymphocyteImmunoglobulin Class SwitchingMediatingB-Cell LymphomasMutationCell DeathChromosomal TranslocationGrowthLymphomaGenesProteinsImmunityImmunoglobulin MBaseDouble Strand Break Repair

Grant awards (28)

RNA-directed targeting of AID in immunity and cancer$531,000
R01 · FY2025 · AI · contact PI
Mechanistic Elucidation of Class Switch Recombination and Somatic Hypermutation$515,070
R01 · FY2025 · AI · contact PI
RNA-directed targeting of AID in immunity and cancer$531,000
R01 · FY2024 · AI · contact PI
Mechanistic Elucidation of Class Switch Recombination and Somatic Hypermutation$531,000
R01 · FY2024 · AI · contact PI
Mechanistic Elucidation of Class Switch Recombination and Somatic Hypermutation$531,000
R01 · FY2023 · AI · contact PI
RNA-directed targeting of AID in immunity and cancer$531,000
R01 · FY2023 · AI · contact PI
RNA-directed targeting of AID in immunity and cancer$531,000
R01 · FY2022 · AI · contact PI
Mechanistic Elucidation of Class Switch Recombination and Somatic Hypermutation$531,000
R01 · FY2022 · AI · contact PI
Mechanistic Elucidation of Class Switch Recombination and Somatic Hypermutation$267,272
R01 · FY2021 · AI · contact PI
Project 2: Characterizing the role of ATM and MSH2 in genome stability$151,149
U54 · FY2021 · CA · contact PI
Mechanistic Elucidation of Class Switch Recombination and Somatic Hypermutation$531,000
R56 · FY2020 · AI · contact PI
RNA-directed targeting of AID in immunity and genomic integrity$449,000
R01 · FY2020 · AI · contact PI
Project 2: Characterizing the role of ATM and MSH2 in genome stability$197,300
U54 · FY2020 · CA · contact PI
Elucidation of Immunoglobulin Class Switch Recombination$439,750
R01 · FY2019 · AI · contact PI
RNA-directed targeting of AID in immunity and genomic integrity$428,500
R01 · FY2019 · AI · contact PI
Project 2: Characterizing the role of ATM and MSH2 in genome stability$197,300
U54 · FY2019 · CA · contact PI
Elucidation of Immunoglobulin Class Switch Recombination$439,750
R01 · FY2018 · AI · contact PI
RNA-directed targeting of AID in immunity and genomic integrity$428,500
R01 · FY2018 · AI · contact PI
Elucidation of Immunoglobulin Class Switch Recombination$439,750
R01 · FY2017 · AI · contact PI
RNA-directed targeting of AID in immunity and genomic integrity$428,500
R01 · FY2017 · AI · contact PI
Elucidation of Immunoglobulin Class Switch Recombination$439,750
R01 · FY2016 · AI · contact PI
RNA-directed targeting of AID in immunity and genomic integrity$428,500
R01 · FY2016 · AI · contact PI
Elucidation of Immunoglobulin Class Switch Recombination$438,958
R01 · FY2015 · AI · contact PI
ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO$436,694
R01 · FY2013 · AI · contact PI
ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO$464,567
R01 · FY2012 · AI · contact PI
ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO$464,567
R01 · FY2011 · AI · contact PI
ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO$469,260
R01 · FY2010 · AI · contact PI
ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO$474,000
R01 · FY2009 · AI · contact PI